Scholar Rock Holding Corporation (SRRK) Stock Analysis
A live, multi-source view of Scholar Rock Holding Corporation (SRRK): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Scholar Rock Holding Corporation
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on improving the lives of children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. The company's novel understanding of the molecular mechanisms of growth factor activation within the transforming growth factor beta (TGFß) superfamily has enabled the development of a proprietary platform. This platform is used for the development of monoclonal antibodies that locally and selectively target the precursor, or latent, forms of growth factors. The company is developing Apitegromab, an inhibitor of the activation of myostatin, which is in a Phase 2 clinical trial for the treatment of SMA and facioscapulohumeral muscular dystrophy (FSHD). Additionally, SRK-439, an anti-pro/latent myostatin antibody, is in a Phase 1 clinical trial for the treatment of patients with rare, severe, and debilitating neuromuscular diseases. SRK-181 is a Phase 2-ready investigational inhibitor of latent TGFß1 for the treatment of patients with solid tumors that are resistant to anti-PD-(L)1 antibody therapies.
Sector: Healthcare · Industry: Biotechnology · United States · 289 employees · scholarrock.com
Key statistics · as of 2026-09-06
As of 2026-09-06, Scholar Rock Holding Corporation (SRRK) had a market capitalization of $6.74B (forward -23.8) and a beta of 0.68; the shares traded in a 52-week range of $27.07 – $61.76 (75.2% over the year).
- Market cap
- $6.74B
- Enterprise value
- $6.45B
- Forward P/E
- -23.8
- Price / book
- 26.51
- EPS (trailing)
- $-3.31
- EPS (forward)
- $-2.33
- Payout ratio
- 0.0%
- 52-week range
- $27.07 – $61.76
- 52-week change
- 75.2%
- Beta
- 0.68
- Average volume
- 1.3M
- Shares outstanding
- 121.8M
- Short % of float
- 18.67%
- Profit margin
- 0.0%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-11
In RapidTradeView’s 2026-09-11 scan of the US universe, Scholar Rock Holding Corporation (SRRK) last closed at $55.67 (the last completed close before that scan).
Technicals at the scan: RSI 52 (neutral territory), price -0.8% versus its 20-day average, 20-day versus 50-day average spread +4.9%, MACD histogram -0.38.
Sentiment inputs: 0% of recent Finnhub-scored headlines read bullish; analyst consensus score 79/100.
Next scheduled company event: in 62 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
RapidTradeView has recorded no Congress or insider filing for SRRK in the last 90 days. Coverage of House, Senate and SEC Form 4 filings began in July 2026, and insider sells are tracked for universe tickers only, so this is our record, not a guarantee that nothing was filed. Who is trading what
RapidTradeView pick record
SRRK has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Scholar Rock Holding Corporation (SRRK) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell SRRK.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.